These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 23546555)

  • 1. Adherence to repeat fecal occult blood testing in an urban community health center network.
    Liss DT; Petit-Homme A; Feinglass J; Buchanan DR; Baker DW
    J Community Health; 2013 Oct; 38(5):829-33. PubMed ID: 23546555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative effectiveness of a multifaceted intervention to improve adherence to annual colorectal cancer screening in community health centers: a randomized clinical trial.
    Baker DW; Brown T; Buchanan DR; Weil J; Balsley K; Ranalli L; Lee JY; Cameron KA; Ferreira MR; Stephens Q; Goldman SN; Rademaker A; Wolf MS
    JAMA Intern Med; 2014 Aug; 174(8):1235-41. PubMed ID: 24934845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic colonoscopy following a positive fecal occult blood test in community health center patients.
    Liss DT; Brown T; Lee JY; Altergott M; Buchanan DR; Newland A; Park JN; Rittner SS; Baker DW
    Cancer Causes Control; 2016 Jul; 27(7):881-7. PubMed ID: 27228991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal adherence with fecal occult blood test screening in community practice.
    Fenton JJ; Elmore JG; Buist DS; Reid RJ; Tancredi DJ; Baldwin LM
    Ann Fam Med; 2010; 8(5):397-401. PubMed ID: 20843880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns and predictors of repeat fecal immunochemical and occult blood test screening in four large health care systems in the United States.
    Singal AG; Corley DA; Kamineni A; Garcia M; Zheng Y; Doria-Rose PV; Quinn VP; Jensen CD; Chubak J; Tiro J; Doubeni CA; Ghai NR; Skinner CS; Wernli K; Halm EA
    Am J Gastroenterol; 2018 May; 113(5):746-754. PubMed ID: 29487413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of a randomized controlled trial to assess the comparative effectiveness of a multifaceted intervention to improve adherence to colorectal cancer screening among patients cared for in a community health center.
    Baker DW; Brown T; Buchanan DR; Weil J; Cameron KA; Ranalli L; Ferreira MR; Stephens Q; Balsley K; Goldman SN; Wolf MS
    BMC Health Serv Res; 2013 Apr; 13():153. PubMed ID: 23627550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adherence to Competing Strategies for Colorectal Cancer Screening Over 3 Years.
    Liang PS; Wheat CL; Abhat A; Brenner AT; Fagerlin A; Hayward RA; Thomas JP; Vijan S; Inadomi JM
    Am J Gastroenterol; 2016 Jan; 111(1):105-14. PubMed ID: 26526080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies.
    Inadomi JM; Vijan S; Janz NK; Fagerlin A; Thomas JP; Lin YV; Muñoz R; Lau C; Somsouk M; El-Nachef N; Hayward RA
    Arch Intern Med; 2012 Apr; 172(7):575-82. PubMed ID: 22493463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Systematic Review of Repeat Fecal Occult Blood Tests for Colorectal Cancer Screening.
    Murphy CC; Sen A; Watson B; Gupta S; Mayo H; Singal AG
    Cancer Epidemiol Biomarkers Prev; 2020 Feb; 29(2):278-287. PubMed ID: 31740521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal Adherence to Immunochemical Fecal Occult Blood Testing vs Guaiac-based FOBT in an Organized Colorectal Cancer Screening Program.
    Benito L; Travier N; Binefa G; Vidal C; Espinosa J; Milà N; Garcia M
    Cancer Prev Res (Phila); 2019 May; 12(5):327-334. PubMed ID: 30890542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of continued mailed fecal tests in the patient-centered medical home: Year 3 of the Systems of Support to Increase Colon Cancer Screening and Follow-Up randomized trial.
    Green BB; Anderson ML; Chubak J; Fuller S; Meenan RT; Vernon SW
    Cancer; 2016 Jan; 122(2):312-21. PubMed ID: 26488332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with adherence to fecal occult blood testing for colorectal cancer screening among adults in the Republic of Korea.
    Bae N; Park S; Lim S
    Eur J Oncol Nurs; 2014 Feb; 18(1):72-7. PubMed ID: 24183583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-year follow-up of the effectiveness of a multifaceted intervention to improve adherence to annual colorectal cancer screening in community health centers.
    Baker DW; Brown T; Goldman SN; Liss DT; Kollar S; Balsley K; Lee JY; Buchanan DR
    Cancer Causes Control; 2015 Nov; 26(11):1685-90. PubMed ID: 26337733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is the patient activation measure associated with adherence to colonoscopy after a positive fecal occult blood test result?
    Azulay R; Valinsky L; Hershkowitz F; Magnezi R
    Isr J Health Policy Res; 2018 Dec; 7(1):74. PubMed ID: 30577883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fecal occult blood testing instructions and impact on patient adherence.
    Bapuji SB; Lobchuk MM; McClement SE; Sisler JJ; Katz A; Martens P
    Cancer Epidemiol; 2012 Aug; 36(4):e258-64. PubMed ID: 22504053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies to improve repeat fecal occult blood testing cancer screening.
    Davis TC; Arnold CL; Bennett CL; Wolf MS; Reynolds C; Liu D; Rademaker A
    Cancer Epidemiol Biomarkers Prev; 2014 Jan; 23(1):134-43. PubMed ID: 24192009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in colonoscopy and fecal occult blood test use after the introduction of dual screening offers in Germany: Results from a large population-based study, 2003-2016.
    Chen C; Stock C; Jansen L; Chang-Claude J; Hoffmeister M; Brenner H
    Prev Med; 2019 Jun; 123():333-340. PubMed ID: 30946858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physician-office vs home uptake of colorectal cancer screening using FOBT/FIT among screening-eligible US adults.
    Chido-Amajuoyi OG; Sharma A; Talluri R; Tami-Maury I; Shete S
    Cancer Med; 2019 Dec; 8(17):7408-7418. PubMed ID: 31637870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving fecal occult blood testing compliance using a mailed educational reminder.
    Lee JK; Reis V; Liu S; Conn L; Groessl EJ; Ganiats TG; Ho SB
    J Gen Intern Med; 2009 Nov; 24(11):1192-7. PubMed ID: 19774423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.